ABSTRACT
Objective@#To assess the clinical effects of transurethral holmium laser enucleation of the prostate (HoLEP) combined with Jisheng Shenqi Decoction (HoLEP + JSSD) on BPH.@*METHODS@#This study included 110 BPH patients treated in our hospital from August 2017 to April 2018, who were randomly assigned to receive HoLEP (n = 55) or HoLEP + JSSD (n = 55). We compared the pre- and post-operative IPSS, quality of life (QOL) score, prostate volume, postvoid residual urine volume (PVR), maximum urinary flow rate (Qmax), average urinary flow rate (Qavg) and levels of serum T, E2 and T/E2 as well as postoperative complications between the two groups of patients.@*RESULTS@#After treatment, both IPSS and QOL score were significantly lower in the HoLEP + JSSD than in the HoLEP group (P 0.05) or the total incidence rate of complications postoperatively (21.82% vs 29.09%, P > 0.05).@*CONCLUSIONS@#HoLEP + JSSD can significantly alleviate the lower urinary tract symptoms as well as improve the QOL and bladder and urinary tract functions of BPH patients.
ABSTRACT
<p><b>OBJECTIVE</b>To investigate a new surgical method for the treatment of prostate cancer with bladder outlet obstruction.</p><p><b>METHODS</b>Forty-seven patients with prostate cancer complicated with bladder outlet obstruction were treated by combined use of transurethral electrovaporization ablation of the prostate (TUVP) and transurethral resection of the prostate (TURP).</p><p><b>RESULTS</b>The operations were successful, with satisfactory results and no serious complication. IPSS decreased from (26.5 +/- 4.8) pre-operatively to (8.5 +/- 2.2) post-operatively (P < 0.05); Qmax increased from (4.6 +/- 1.5) ml/s to (14.5 +/- 3.6) ml/s (P < 0.05); and PSA decreased from (58.1 +/- 7.2) microg/L to (3.6 +/- 1.8) microg/L (P < 0.01).</p><p><b>CONCLUSION</b>The combined use of TUVP and TURP is a safe and ideal method for the treatment of prostate cancer with bladder outlet obstruction.</p>
Subject(s)
Aged , Aged, 80 and over , Humans , Male , Electrosurgery , Follow-Up Studies , Orchiectomy , Prostate-Specific Antigen , Metabolism , Prostatic Neoplasms , General Surgery , Transurethral Resection of Prostate , Methods , Treatment Outcome , Urinary Bladder Neck Obstruction , General SurgeryABSTRACT
<p><b>OBJECTIVE</b>To investigate a new operation method for the treatment of benign prostate hyperplasia(BPH).</p><p><b>METHODS</b>One hundred and seventy-nine patients with BPH were treated by the combined use of transurethral electrovaporization ablation of the prostate(TUVP) and transurethral resection of the prostate(TURP).</p><p><b>RESULTS</b>The procedure was successful and the results were satisfactory, with little bleeding and no serious complication. IPSS decreased from 29.0 preoperatively to 7.6 postoperatively (P < 0.05) and Qmax increased from 5.8 ml/s preoperatively to 14.8 ml/s postoperatively(P < 0.05).</p><p><b>CONCLUSIONS</b>The combined use of TUVP and TURP is a safe, effective and ideal method for the treatment of BPH.</p>